137 related articles for article (PubMed ID: 29534468)
1. ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens.
Takagi K; Miki Y; Onodera Y; Ishida T; Watanabe M; Sasano H; Suzuki T
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534468
[TBL] [Abstract][Full Text] [Related]
2. Krüppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens.
Takagi K; Miki Y; Onodera Y; Nakamura Y; Ishida T; Watanabe M; Inoue S; Sasano H; Suzuki T
Endocr Relat Cancer; 2012 Dec; 19(6):741-50. PubMed ID: 22936544
[TBL] [Abstract][Full Text] [Related]
3. Forkhead box P3 regulates ARHGAP15 expression and affects migration of glioma cells through the Rac1 signaling pathway.
Sun Z; Zhang B; Wang C; Fu T; Li L; Wu Q; Cai Y; Wang J
Cancer Sci; 2017 Jan; 108(1):61-72. PubMed ID: 27862679
[TBL] [Abstract][Full Text] [Related]
4. Amyloid precursor protein in human breast cancer: an androgen-induced gene associated with cell proliferation.
Takagi K; Ito S; Miyazaki T; Miki Y; Shibahara Y; Ishida T; Watanabe M; Inoue S; Sasano H; Suzuki T
Cancer Sci; 2013 Nov; 104(11):1532-8. PubMed ID: 23889773
[TBL] [Abstract][Full Text] [Related]
5. Rac1 activation in human breast carcinoma as a prognostic factor associated with therapeutic resistance.
Yamaguchi M; Takagi K; Sato A; Miki Y; Miyashita M; Sasano H; Suzuki T
Breast Cancer; 2020 Sep; 27(5):919-928. PubMed ID: 32314182
[TBL] [Abstract][Full Text] [Related]
6. Rho GTPase activating protein 15 (arhGAP15) siRNA effect apoptosis-induced by ethanol in bovine fibroblast cells.
Ullah I; Lee HY; Kim MJ; Shah SA; Badshah H; Kim TH; Chung HJ; Yang BC; Kim MO
Pak J Pharm Sci; 2013 May; 26(3):605-10. PubMed ID: 23625437
[TBL] [Abstract][Full Text] [Related]
7. Disruption of ArhGAP15 results in hyperactive Rac1, affects the architecture and function of hippocampal inhibitory neurons and causes cognitive deficits.
Zamboni V; Armentano M; Sarò G; Ciraolo E; Ghigo A; Germena G; Umbach A; Valnegri P; Passafaro M; Carabelli V; Gavello D; Bianchi V; D'Adamo P; de Curtis I; El-Assawi N; Mauro A; Priano L; Ferri N; Hirsch E; Merlo GR
Sci Rep; 2016 Oct; 6():34877. PubMed ID: 27713499
[TBL] [Abstract][Full Text] [Related]
8. Identification of androgen-responsive microRNAs and androgen-related genes in breast cancer.
Nakano K; Miki Y; Hata S; Ebata A; Takagi K; McNamara KM; Sakurai M; Masuda M; Hirakawa H; Ishida T; Suzuki T; Ohuchi N; Sasano H
Anticancer Res; 2013 Nov; 33(11):4811-9. PubMed ID: 24222117
[TBL] [Abstract][Full Text] [Related]
9. ArhGAP15, a novel human RacGAP protein with GTPase binding property.
Seoh ML; Ng CH; Yong J; Lim L; Leung T
FEBS Lett; 2003 Mar; 539(1-3):131-7. PubMed ID: 12650940
[TBL] [Abstract][Full Text] [Related]
10. Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migration.
Takagi K; Miki Y; Tanaka S; Hashimoto C; Watanabe M; Sasano H; Ito K; Suzuki T
Endocr J; 2016; 63(3):287-99. PubMed ID: 26842712
[TBL] [Abstract][Full Text] [Related]
11. CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance.
Minemura H; Takagi K; Sato A; Takahashi H; Miki Y; Shibahara Y; Watanabe M; Ishida T; Sasano H; Suzuki T
Cancer Sci; 2016 Dec; 107(12):1898-1908. PubMed ID: 27627783
[TBL] [Abstract][Full Text] [Related]
12. ARHGAP15 regulates lung cancer cell proliferation and metastasis via the STAT3 pathway.
Liu ZD; Mou ZX; Che XH; Wang K; Li HX; Chen XY; Guo XM
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5840-5850. PubMed ID: 31298335
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
[TBL] [Abstract][Full Text] [Related]
14. RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis.
Wang Q; Wang JY; Zhang XP; Lv ZW; Fu D; Lu YC; Hu GH; Luo C; Chen JX
Carcinogenesis; 2013 Apr; 34(4):916-26. PubMed ID: 23276796
[TBL] [Abstract][Full Text] [Related]
15. Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.
Milde-Langosch K; Karn T; Müller V; Witzel I; Rody A; Schmidt M; Wirtz RM
Breast Cancer Res Treat; 2013 Jan; 137(1):57-67. PubMed ID: 23135572
[TBL] [Abstract][Full Text] [Related]
16. Expression of AR, 5αR1 and 5αR2 in bladder urothelial carcinoma and relationship to clinicopathological factors.
Hata S; Ise K; Azmahani A; Konosu-Fukaya S; McNamara KM; Fujishima F; Shimada K; Mitsuzuka K; Arai Y; Sasano H; Nakamura Y
Life Sci; 2017 Dec; 190():15-20. PubMed ID: 28947209
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome c1 as a favorable prognostic marker in estrogen receptor-positive breast carcinoma.
Sato A; Takagi K; Miki Y; Yoshimura A; Hara M; Ishida T; Sasano H; Suzuki T
Histol Histopathol; 2019 Dec; 34(12):1365-1375. PubMed ID: 31149728
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of thymidylate synthase as a favorable prognostic marker in estrogen receptor-positive breast carcinoma.
Takagi K; Miki Y; Nakamura Y; Hirakawa H; Kakugawa Y; Amano G; Watanabe M; Ishida T; Sasano H; Suzuki T
Histol Histopathol; 2015 Oct; 30(10):1223-32. PubMed ID: 25873048
[TBL] [Abstract][Full Text] [Related]
19. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
[TBL] [Abstract][Full Text] [Related]
20. 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production.
Suzuki T; Miki Y; Moriya T; Akahira J; Ishida T; Hirakawa H; Yamaguchi Y; Hayashi S; Sasano H
Int J Cancer; 2007 Jan; 120(2):285-91. PubMed ID: 17066438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
